Key Players
Competitive Landscape
Licorice extract suppliers compete on different parts of the buying decision. Food processors first compare physical form and plant handling, since powder, paste, granules and blocks need different dosing systems. Nutraceutical and cosmetic buyers pay more attention to marker levels, while pharmaceutical buyers may need a purified active. MAFCO Worldwide LLC, Norevo GmbH and Licorice Extract LLC cover direct forms. Huisong Pharmaceuticals, Sabinsa Corporation and Sunpure Extracts Pvt Ltd sell standardized extracts, and Indena S.p.A. supplies purified 18β-glycyrrhetinic acid. No shared specification covers all three use cases, so the market remains fragmented.
Supplier activity since April 2025 shows a move toward clearer forms, assays and local distribution routes. In May 2026, BGG Europe listed powders and blocks beside licorice-derived flavonoids at Vitafoods Europe. Indena's October 2025 list specified 18β-glycyrrhetinic acid at 98.0% to 101.0% assay. Norevo's August 2025 material listed powder, paste, granules and blocks for confectionery. Swisseutic added a European distribution route for purified licorice derivatives in April 2025. For buyers, these developments separate three commercial choices that broad licorice labels often combine: physical form, chemical definition and regional access.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| May 2026: BGG Europe listed licorice powders, blocks, flavonoids and licorice derivatives in its Vitafoods Europe exhibitor profile. | Ingredient buyers need distinct extract and derivative forms for food, cosmetic and nutraceutical formulation routes. | Supplier portfolios are separating whole extracts from purified licorice derivatives with defined chemical identity. | Broader format and derivative choice can shorten early screening when buyers already know the target function. |
| October 2025: Indena S.p.A. published a pharmaceutical list with 18β-glycyrrhetinic acid at 98.0% to 101.0% assay. | Pharmaceutical buyers need narrow active-content ranges for purified licorice-derived ingredients. | Licorice-derived products are extending from general extracts into tightly specified active molecules. | High-assay actives can support applications that require narrower composition than general botanical extracts. |
| August 2025: Norevo GmbH documented licorice granules, powder, low-dust powder, paste and blocks for confectionery use. | Confectionery plants need physical forms that fit different dosing and handling systems. | Suppliers are keeping several licorice presentations instead of forcing one format into every process. | Format choice can reduce conversion work when a recipe moves between plant handling systems. |
| April 2025: Swisseutic announced a European distribution partnership covering licorice derivatives and purified extracts. | European buyers need local access to defined licorice derivatives for regulated and formulation-sensitive uses. | Distribution partnerships are widening regional access to purified licorice actives without changing their technical identity. | A local distribution route can reduce sourcing friction before customer-specific qualification begins. |
Source: Future Market Insights, Licorice Extract Market Report, 2026-2036.
MAFCO Worldwide LLC, Norevo GmbH and Licorice Extract LLC focus on direct forms used during formulation. Huisong Pharmaceuticals, Sabinsa Corporation, Sunpure Extracts Pvt Ltd and Indena S.p.A. supply standardized extracts or defined licorice-derived actives.
How do companies position their licorice extract offerings?
Company positioning usually starts with the buyer's first technical problem. MAFCO Worldwide LLC and Norevo GmbH offer direct formats that fit food and beverage processing. Huisong Pharmaceuticals publishes marker ranges so buyers can compare standardized composition before approval. Indena S.p.A. supplies a purified active for pharmaceutical qualification where narrower analytical specifications apply. The routes compete on different decisions, including plant handling, composition control and pharmaceutical release.
Which suppliers document qualification or assay controls?
Qualification evidence changes according to the finished product and intended use. Food teams usually begin with physical form and intended flavor function. Regulated herbal buyers place more weight on botanical identity and assay method. A material can run well in production but still fail local release if the test method differs from the buyer's procedure. Supplier documents need to match the finished-product route before commercial approval.
Which companies extend beyond basic extract supply?
Some suppliers differentiate licorice through active level as well as extract form. Sabinsa Corporation and Sunpure Extracts Pvt Ltd document standardized compositions for nutraceutical or cosmetic use. Huisong Pharmaceuticals publishes marker ranges, while Indena S.p.A. supplies a purified active for pharmaceutical use. Active-level specifications affect dosage controls, release tests and formulation limits even though the ingredients share the same botanical origin.
Which companies document multi-region customer support?
Multi-region supply reduces procurement work for the same licorice ingredient sold under different country rules. Huisong Pharmaceuticals documents an international supply chain for natural ingredients. Norevo GmbH lists operations in Europe, Asia and Latin America, while Sabinsa Corporation documents international manufacturing and commercial operations. A buyer can keep one supplier relationship while changing certificates and release documents for each local qualification system. Fewer supplier changes can simplify sourcing as one formulation moves into more than one regulated market.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| MAFCO Worldwide LLC | Direct licorice specialist with food and specialty formulation routes. | Current MagnaSweet products are derived from glycyrrhizic acid obtained from licorice root. |
| Norevo GmbH | Licorice supplier with several physical forms for confectionery and beverage production. | Current product information lists powder, paste, granules, and blocks for direct formulation use. |
| Huisong Pharmaceuticals | Standardized botanical extract supplier with published licorice marker specifications. | Current licorice extract specifications include defined glycyrrhizic acid and liquiritin ranges. |
| Sabinsa Corporation | Standardized botanical ingredient supplier with multiple licorice-derived specifications. | Current portfolio lists Licorice Dry Extract and deglycyrrhizinated licorice with defined glycyrrhizin levels. |
| Indena S.p.A. | Botanical pharmaceutical ingredient supplier with a purified licorice-derived active. | Current 18β-glycyrrhetinic acid product information supports pharmaceutical qualification of the defined molecule. |
| Sunpure Extracts Pvt Ltd | Botanical extract supplier with glycyrrhizin and glabridin-based licorice products. | Current portfolio lists glabridin and monoammonium glycyrrhizinate products under documented specifications. |
| Licorice Extract LLC | Direct supplier of licorice formats for food and industrial formulation routes. | Current product line includes spray-dried powder, paste, and granulated licorice extract. |
Research Methodology
Current product pages and official company documents form the evidence base for the company review. Physical form, marker control and application evidence are assessed separately to match the buyer decision each one affects. Geographic records are used only to show documented commercial reach. Public company evidence is kept separate from the report's proprietary market estimates. Portfolio breadth and geographic reach are not converted into market-share or product-quality judgments for the 2026 to 2036 forecast.